Clinical Trial Update: A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities) [Phase 3]

View source ↗

Summary

A Phase 3 multi-center trial evaluated the safety and efficacy of PEP005 (ingenol mebutate) gel for actinic keratoses on the trunk and extremities, and the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 (Ingenol Mebutate) Gel (Ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED